Effect of cell-based intercellular delivery of transcription factor GATA4 on ischemic cardiomyopathy

Circulation Research

Volumn 100, Issue 11, 2007, Pages 1626-1633

  Bian, Jing ^a,b   Popović, Zoran B ^a   Benejam, Carlos ^a   Kiedrowski, Matthew ^a   Rodriguez, L Leonardo ^a   Penn, Marc S ^a,b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Cleveland State University   (United States)

^c Bakken Heart Brain Institute   (United States)

Author keywords

Cell based gene therapy; GATA4; Intercellular delivery of protein; Myocardial infarct; VP22

Indexed keywords

GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MYOSIN; TRANSCRIPTION FACTOR GATA 4 PROTEIN VP22 COMPLEX; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FIBROBLAST; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

ANIMALS; CELL SIZE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FIBROBLASTS; GATA4 TRANSCRIPTION FACTOR; GENE THERAPY; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; RATS; RATS, INBRED LEW; RECOMBINANT FUSION PROTEINS; TRANSFECTION; VENTRICULAR FUNCTION, LEFT; VIRAL STRUCTURAL PROTEINS;

EID: 34250162152     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000269778.75877.68     Document Type: Article

References (32)

1. Oka T, Maillet M, Watt AJ, Schwartz RJ, Aronow BJ, Duncan SA, Molkentin JD. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res. 2006;98:837-845.
2. Bisping E, Ikeda S, Kong SW, Tarnavski O, Bodyak N, McMullen JR, Rajagopal S, Son JK, Ma Q, Springer Z, Kang PM, Izumo S, Pu WT. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc Natl Acad Sci U S A. 2006;103:14471-14476.
3. Kobayashi S, Lackey T, Huang Y, Bisping E, Pu WT, Boxer LM, Liang Q. Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo. FASEB J. 2006;20:800-802.
4. Yau TM, Fung K, Weisel RD, Fujii T, Mickle DA, Li RK. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation. 2001;104(suppl I):I-218-I-222.
5. Askari A, Unzek S, Goldman CK, Kiedrowski M, Forudi F, Ellis SG, Thomas JD, Topol EJ, DiCorleto PE, Penn MS. Cellular, but not direct adenoviral delivery of VEGF results in improved LV function and neo-vascularization in dilated ischemic cardiomyopathy. J Am Coll Cardiol. 2004;43:1908-1914.
6. Askari A, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS. Effect of stromal-cell-derived factor-1 on stem cell homing and tissue regeneration in ischemic cardiomyopathy. Lancet. 2003;362:697-703.
7. Lundberg P, Langel U. A brief introduction to cell-penetrating peptides. J Mol Recognit. 2003;16:227-233.
8. Maiolo JR, Ferrer M, Ottinger EA. Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. Biochim Biophys Acta. 2005;1712:161-172.
9. Green KL, Southgate TD, Mulryan K, Fairbairn LJ, Stern PL, Gaston K. Diffusible VP22-E2 protein kills bystander cells and offers a route for cervical cancer gene therapy. Hum Gene Ther. 2006;17:147-157.
10. Lee KC, Hamstra DA, Bullarayasamudram S, Bhojani MS, Moffat BA, Dornfeld KJ, Ross BD, Rehemtulla A. Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit. Gene Ther. 2006;13:127-137.
11. Suzuki K, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y, Yacoub MH. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation. 2001;104(suppl I):I-207-I-212.
12. Bian J, Kiedrowski M, Mal N, Forudi F, Penn MS. Engineered cell therapy for sustained local myocardial delivery of nonsecreted proteins. Cell Transplant. 2006;15:67-74.
13. Molkentin JD. The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem. 2000;275:38949-38952.
14. Schenk S, Mal N, Finan A, Zhang M, Kiedrowski M, Popovic Z, McCarthy PM, Penn MS. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells. 2007;25:245-251.
15. Popovic ZB, Benejam C, Bian J, Mal N, Drinko J, Lee K, Forudi F, Reeg R, Greenberg NL, Thomas JD, Penn MS. Speckle tracking echocardiography correctly identifies segmental left ventricular dysfunction induced by scarring in a rat model of myocardial infarction. Am J Physiol Heart Circ Physiol. In press.
16. Cho GY, Chan J, Leano R, Strudwick M, Marwick TH. Comparison of two-dimensional speckle and tissue velocity based strain and validation with harmonic phase magnetic resonance imaging. Am J Cardiol. 2006;97:1661-1666.
17. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975;56:56-64.
18. Rota M, Boni A, Urbanek K, Padin-Iruegas ME, Kajstura TJ, Fiore G, Kubo H, Sonnenblick EH, Musso E, Houser SR, Leri A, Sussman MA, Anversa P. Nuclear targeting of Akt enhances ventricular function and myocyte contractility. Circ Res. 2005;97:1332-1341.
19. Misao J, Hayakawa Y, Ohno M, Kato S, Fujiwara T, Fujiwara H. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation. 1996;94:1506-1512.
20. Liang Q, De Windt LJ, Witt SA, Kimball TR, Markham BE, Molkentin JD. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem. 2001;276:30245-30253.
21. Grepin C, Nemer G, Nemer M. Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor. Development. 1997;124:2387-2395.
22. Suzuki YJ, Nagase H, Day RM, Das DK. GATA-4 regulation of myocardial survival in the preconditioned heart. J Mol Cell Cardiol. 2004;37:1195-1203.
23. Watt AJ, Battle MA, Li J, Duncan SA. GATA4 is essential for formation of the proepicardium and regulates cardiogenesis. Proc Natl Acad Sci U S A. 2004;101:12573-12578.
24. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS, Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC, Srivastava D. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature. 2003;424:443-447.
25. Molkentin JD, Lin Q, Duncan SA, Olson EN. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 1997;11:1061-1072.
26. Delhaas T, Arts T, Bovendeerd PH, Prinzen FW, Reneman RS. Sub-epicardial fiber strain and stress as related to left ventricular pressure and volume. Am J Physiol. 1993;264:H1548-H1559.
27. Kaseda S, Tomoike H, Ogata I, Nakamura M. End-systolic pressure-volume, pressure-length, and stress-strain relations in canine hearts. Am J Physiol. 1985;249:H648-H654.
28. Rohde LE, Aikawa M, Cheng GC, Sukhova G, Solomon SD, Libby P, Pfeffer J, Pfeffer MA, Lee RT. Echocardiography-derived left ventricular end-systolic regional wall stress and matrix remodeling after experimental myocardial infarction. J Am Coll Cardiol. 1999;33:835-842.
29. DiDonato M, Toso A, Dor V, Sabatier M, Menicanti L, Fantini F, Buckberg G. Mechanical synchrony: role of surgical ventricular restoration in correcting LV dyssynchrony during chamber rebuilding. Heart Fail Rev. 2004;9:307-315.
30. Mills WR, Mal N, Kiedrowski MJ, Unger R, Forudi F, Popovic ZB, Penn MS, Laurita KR. Stem cell therapy enhances electrical viability in myocardial infarction. J Mol Cell Cardiol. 2007;42:304 -314.
31. Deglurkar I, Mal N, Mills WR, Popovic ZB, McCarthy P, Blackstone EH, Laurita KR, Penn MS. Mechanical and electrical effects of cell-based gene therapy for ischemic cardiomyopathy are independent. Hum Gene Ther. 2006;17:1144-1151.
32. Dietz GP, Kilic E, Bahr M. Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction. Mol Cell Neurosci. 2002;21:29-37.